KESTRA MEDICAL TECHNOLOGIES, LTD.
KMTSNasdaq
$24.42
↑ +1.8%Jul 17 close · end-of-day
Price
1Y↑ +59.1%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$1.3B
Enterprise Value
$1.2B
P/E
—
P/S
13.9
P/B
5.1
EV/EBITDA
—
PEG
—
FCF Yield
-8.8%
Dividend Yield
—
Revenue (TTM)
$95.1M
Net Income (TTM)
-$131.6M
Free Cash Flow (TTM)
-$116.6M
Gross Margin
51.4%
Operating Margin
-141.6%
Net Margin
-138.4%
ROE
-50.7%
ROIC
-100.5%
Debt / Equity
0.2
Net Cash
$153.8M
Return 1Y
+48.4%
Company profile
We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. Kestra Medical Technologies, Ltd. is located in Kirkland, Washington.
- CEO
- Brian Webster
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 300
- Headquarters
- Washington
- Website
- www.kestramedical.com
Management & directors
- Moran Timothy P.Chief Business Officer
- Ford Alfred J JrChief Commercial Officer
- Mahboob VaseemChief Financial Officer
- Umberger Traci SSee Remarks
- Webster Brian DanielSee Remarks
Roles derived from SEC Form 4 filings.
Earnings
KMTS Q4 2026 Earnings
Period ends 2026-04-30
MetricActualYoY
Revenue$28.6M↑ +66.2%
Diluted EPS-$0.68↓ -56.7%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
| Revenue | $27.8M | $59.8M | $95.1M |
| Gross profit | $362,000.00 | $24.2M | $48.9M |
| Operating income | -$85.1M | -$106.4M | -$134.7M |
| Net income | -$94.1M | -$113.8M | -$131.6M |
| Diluted EPS | -$5.07 | -$5.13 | -$2.43 |
| Operating cash flow | -$72.2M | -$77.6M | -$81.7M |
| Free cash flow | -$84.5M | -$100.5M | -$116.6M |
| Gross margin | 1.3% | 40.5% | 51.4% |
| Operating margin | -305.8% | -177.8% | -141.6% |
| Net margin | -338.4% | -190.3% | -138.4% |
| Line item | Q1 '24 | Q2 '24 | Q3 '25 | Q4 '25 | Q1 '25 | Q2 '25 | Q3 '26 | Q4 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.8M | $14.7M | $15.1M | $17.2M | $19.4M | $22.6M | $24.6M | $28.6M |
| Gross profit | $4.2M | $5.8M | $6.5M | $7.6M | $8.9M | $11.4M | $12.9M | $15.7M |
| Operating income | -$18.4M | -$19.1M | -$20.6M | -$48.2M | -$28.9M | -$31.8M | -$34.8M | -$39.3M |
| Net income | -$19.9M | -$20.4M | -$21.5M | -$52.1M | -$25.8M | -$32.8M | -$34.2M | -$38.8M |
| Diluted EPS | -$1.12 | -$1.19 | -$1.25 | -$1.57 | -$0.50 | -$0.64 | -$0.61 | -$0.68 |
| Operating cash flow | -$17.5M | -$18.1M | -$18.0M | -$24.1M | -$26.3M | -$18.3M | -$18.4M | -$18.7M |
| Free cash flow | -$24.5M | -$22.5M | -$22.1M | -$31.4M | -$34.4M | -$25.6M | -$28.2M | -$28.4M |
| Gross margin | 32.9% | 39.6% | 43.4% | 44.3% | 45.7% | 50.6% | 52.6% | 54.8% |
| Operating margin | -144.2% | -130.1% | -136.5% | -279.8% | -149.1% | -140.7% | -141.6% | -137.4% |
| Net margin | -155.6% | -138.5% | -142.5% | -302.1% | -133.3% | -145.3% | -139.2% | -135.6% |
Company news
Jul 14, 2026
- 5d agoKestra Medical Technologies Q4 Earnings Call Highlightsmarketbeat.com
- 5d agoKestra Medical Technologies, Ltd. (KMTS) Reports Q4 Loss, Tops Revenue Estimatesfinance.yahoo.com
- 6d agoKestra Medical Technologies Secures Up to $200 Million of Non-Dilutive Financingfinance.yahoo.com
- 6d agoKestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2026 Financial Resultsfinance.yahoo.com
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-16 | Moran Timothy P.· Chief Business Officer | Award | 39,113 | $0.00 | $0.00 | filing |
| 2026-07-15 | Webster Brian Daniel· See Remarks | Sale | 11,216 | $22.01 | $246,869.77 | filing |
| 2026-07-15 | Webster Brian Daniel· See Remarks | Sale | 3,000 | $24.00 | $71,994.90 | filing |
| 2026-07-15 | Webster Brian Daniel· See Remarks | Sale | 784 | $22.63 | $17,744.51 | filing |
| 2026-07-15 | Ford Alfred J Jr· Chief Commercial Officer | Award | 58,832 | $0.00 | $0.00 | filing |
| 2026-07-15 | Mahboob Vaseem· Chief Financial Officer | Award | 44,118 | $0.00 | $0.00 | filing |
| 2026-07-15 | Umberger Traci S· See Remarks | Award | 58,832 | $0.00 | $0.00 | filing |
| 2026-07-15 | Webster Brian Daniel· See Remarks | Award | 176,470 | $0.00 | $0.00 | filing |
| 2026-06-30 | Umberger Traci S· See Remarks | Award | 942 | $21.55 | $20,300.10 | filing |
| 2026-06-30 | Moran Timothy P.· Chief Business Officer | Award | 227 | $21.55 | $4,891.85 | filing |
| 2026-06-15 | Webster Brian Daniel· See Remarks | Sale | 15,000 | $20.81 | $312,142.50 | filing |
| 2026-06-03 | Mahboob Vaseem· Chief Financial Officer | Award | 25,227 | $0.00 | $0.00 | filing |
| 2026-06-03 | Moran Timothy P.· Chief Business Officer | Award | 22,704 | $0.00 | $0.00 | filing |
| 2026-06-03 | Ford Alfred J Jr· Chief Commercial Officer | Award | 25,227 | $0.00 | $0.00 | filing |
| 2026-06-03 | Umberger Traci S· See Remarks | Award | 25,227 | $0.00 | $0.00 | filing |
| 2026-06-03 | Webster Brian Daniel· See Remarks | Award | 75,681 | $0.00 | $0.00 | filing |
| 2026-05-15 | Webster Brian Daniel· See Remarks | Sale | 8,155 | $20.53 | $167,411.55 | filing |
| 2026-05-15 | Webster Brian Daniel· See Remarks | Sale | 6,845 | $21.46 | $146,917.66 | filing |
| 2026-04-15 | Webster Brian Daniel· See Remarks | Sale | 15,000 | $20.04 | $300,670.50 | filing |
| 2026-03-26 | COHEN RAYMOND W | Buy | 10,000 | $19.98 | $199,800.00 | filing |
| 2026-03-17 | Webster Brian Daniel· See Remarks | Sale | 15,000 | $20.27 | $304,123.50 | filing |
| 2026-03-11 | Reilly Kevin C | Award | 8,300 | — | — | filing |
| 2026-02-17 | Webster Brian Daniel· See Remarks | Sale | 11,635 | $25.39 | $295,455.70 | filing |
| 2026-02-17 | Webster Brian Daniel· See Remarks | Sale | 3,272 | $26.29 | $86,036.26 | filing |
| 2026-02-17 | Webster Brian Daniel· See Remarks | Sale | 93 | $27.18 | $2,527.64 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.